Bisulfite treatment creates the chemical distinction measured by the assay. Unmethylated cytosines are converted to uracil, whereas methylated cytosines remain unchanged. After labeling, these sequence differences affect how DNA interacts with methylation-sensitive probes. The resulting probe signals therefore provide a basis for estimating methylation levels at individual CpG sites across many genomic locations.
Probes are designed to respond differently to DNA sequences altered or preserved by bisulfite treatment. Labeled DNA hybridizes to these probes, and the resulting fluorescence intensity reflects the methylation state represented at a specific CpG site. Comparing signal patterns across sites allows researchers to calculate methylation levels and examine genome-wide epigenetic differences between samples.
CpG sites provide defined genomic positions at which methylation can be measured and compared. When groups of sites show different methylation levels between tissues or conditions, researchers can identify differentially methylated regions. These patterns help connect epigenetic variation with gene regulation, genomic imprinting, development, disease, environmental exposure, or treatment response.
A typical workflow begins with DNA treatment using bisulfite, followed by labeling of the treated DNA. The labeled material is then hybridized to methylation-sensitive probes on the array. Fluorescence is measured after hybridization, and those signals are used to calculate methylation levels at targeted CpG sites, producing a broad profile for comparison across samples.
Researchers may choose this approach when they need methylation measurements across thousands of genomic sites rather than a narrowly selected locus. It supports comparisons among tissues and can reveal epigenetic patterns associated with development, disease, environmental exposure, or treatment response. The broad profiling strategy is particularly useful for investigating genome-wide regulation and candidate biomarkers.
Methylation profiles can show how epigenetic patterns differ among tissues, biological conditions, or treatment groups. Researchers can use these comparisons to identify differentially methylated regions and investigate possible biomarkers. In genetics, the profiles also support studies of gene regulation and genomic imprinting, linking methylation patterns with developmental or disease-related states.